Indefinite Delivery Contract SPE2DX15D9765

This is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of a comprehensive range of pharmaceutical products and medical supplies. The contract, valued at $4,999,999, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The task orders issued under this IDC include firm fixed-price delivery orders for specialized medications such as Xolair, Trikafta, Keytruda, Botox, Nucala, and various other prescription drugs and medical supplies across multiple product categories, including injections, tablets, creams, auto-injectors, and specialty pharmaceuticals. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards. The period of performance for this IDC is from April 2015 through December 2025, with the place of performance being DMS Pharmaceutical Group's facility in Park Ridge, Illinois.